scholarly journals A Review of Guidelines for Antibiotic Prophylaxis before Invasive Dental Treatments

2020 ◽  
Vol 11 (1) ◽  
pp. 311
Author(s):  
Abdulaziz A. Bakhsh ◽  
Husain Shabeeh ◽  
Francesco Mannocci ◽  
Sadia Ambreen Niazi

Bacteraemia associated with invasive dental treatments can propagate infective endocarditis in high-risk cardiac patients. Over the past decade, antibiotic prophylaxis before dental treatment has been questioned. This review aims to compare the variations between the UK, European and American antibiotic prophylaxis guidelines before dental treatments. Antibiotic prophylaxis guidelines by the National Institute for Health and Care Excellence (NICE)—Clinical Guideline 64, Scottish Dental Clinical Effectiveness Programme (SDCEP), American Heart Association (AHA), European Society of Cardiology (ESC), European Society of Endodontology (ESE) and Belgian Health Care Knowledge Centre (KCE) position statements were compared regarding the indications, high-risk patients and prophylaxis regimens before dental treatments. In the United Kingdom, the NICE—Clinical Guideline 64 and SDCEP—Implementation Advice do not advise the prescription of prophylactic antibiotics for the majority of high-risk cardiac patients undergoing routine dental treatments. On the contrary, the AHA, ESC and KEC recommend the prescription of antibiotics prior to invasive dental procedures in high-risk cardiac individuals. The ESE also indicates prophylaxis before endodontic procedures for patients with other conditions, including impaired immunologic function, prosthetic joint replacement, high-dose jaw irradiation and intravenous bisphosphonates. Among these guidelines, there are variations in antibiotic prophylaxis regimens. There are variations regarding the indications and antibiotic prophylaxis regimens before invasive dental treatments among these available guidelines.

1984 ◽  
Vol 70 (3) ◽  
pp. 149-159
Author(s):  
A. J. Woodman

SummaryA review of the rationale for the use of antibiotic prophylaxis to prevent the effects of bacteraemia associated with dental treatment is presented with the background to the development of currently recommended high-dose prescribing. The results of a survey within the Armed Services into the current use of antibiotic prophylaxis indicate a wide variety of prescribing schedules, mostly considered effective by accepted standards. However, the use of antibiotics when penicillin hypersensitivity exists was often associated with doses considered ineffective against bacteraemia. The readiness to prescribe repeated prophylaxis was indicative of a lack of awareness of the problems of resistance within the Services for oral prophylaxis which was provided for most medical conditions in a responsible manner. Most replies indicated that there was room for improvement in communication between the patient and medical and dental practitioners regarding the dental involvement in infective endocarditis.


2009 ◽  
Vol 1 (1) ◽  
pp. 7 ◽  
Author(s):  
Marthinus J. Kotzé

Current international and national prophylactic antibiotic regimens have been analyzed in respect of the prevention of bacteremia after dental and surgical procedures and, therefore, of joint prosthesis infection. This information was used to formulate guidelines for the Department of Maxillofacial and Oral Surgery. Publications since 2003 were used in this research. In addition, recommendations of accredited institutions and associations were examined. These included the guidelines of the American Dental Association in association with the American Academy of Orthopaedic Surgeons (2003), the American Heart Association (2007), the Working Party of the British Society for Antimicrobial Chemotherapy (2006) and the Australian Dental Guidelines (2005). No guidelines published by any institution in South Africa were found. The general rationale for the use of antibiotic prophylaxis for surgical (including dental) interventions is that those procedures may result in a bacteremia that may cause infection in joint prostheses. Antibiotics, however, should therefore be administered to susceptible patients, e.g. immunocompromised patients, prior to the development of bacteremia. The guidelines recommended for use in South Africa are based solely on those used outside South Africa. South Africa is regarded as a developing country with its own population and demographic characteristics. Eleven percent of our population is infected with HIV, and a specific guideline for prophylactic antibiotic treatment is, therefore, essential.


2020 ◽  
Vol 34 (3) ◽  
pp. 594-600 ◽  
Author(s):  
Vladimir V. Lomivorotov ◽  
Gleb Moroz ◽  
Samandar Ismoilov ◽  
Vladimir Shmyrev ◽  
Sergey Efremov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document